Business Description
Creo Medical Group PLC
ISIN : GB00BZ1BLL44
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.69 | |||||
Equity-to-Asset | 0.68 | |||||
Debt-to-Equity | 0.3 | |||||
Debt-to-EBITDA | -0.68 | |||||
Piotroski F-Score | 5/9 | |||||
Beneish M-Score | -2.05 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.1 | |||||
3-Year EBITDA Growth Rate | 21 | |||||
3-Year EPS without NRI Growth Rate | 17.8 | |||||
3-Year FCF Growth Rate | 10.7 | |||||
3-Year Book Growth Rate | -24.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 29.68 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 79.69 | |||||
9-Day RSI | 72.59 | |||||
14-Day RSI | 65.14 | |||||
6-1 Month Momentum % | -50 | |||||
12-1 Month Momentum % | -54.76 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.24 | |||||
Quick Ratio | 2.38 | |||||
Cash Ratio | 0.99 | |||||
Days Inventory | 195.62 | |||||
Days Sales Outstanding | 98.78 | |||||
Days Payable | 124.05 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -30.2 | |||||
Shareholder Yield % | -1.26 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 49.51 | |||||
Operating Margin % | -82.84 | |||||
Net Margin % | -73.93 | |||||
FCF Margin % | -71.95 | |||||
ROE % | -38.14 | |||||
ROA % | -28.64 | |||||
ROIC % | -41.23 | |||||
ROC (Joel Greenblatt) % | -107.14 | |||||
ROCE % | -36.22 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.29 | |||||
PB Ratio | 1.47 | |||||
Price-to-Tangible-Book | 3.17 | |||||
EV-to-EBIT | -3.38 | |||||
EV-to-Forward-EBIT | -4.73 | |||||
EV-to-EBITDA | -3.94 | |||||
EV-to-Forward-EBITDA | -5.2 | |||||
EV-to-Revenue | 2.73 | |||||
EV-to-Forward-Revenue | 2.77 | |||||
EV-to-FCF | -3.84 | |||||
Price-to-Net-Current-Asset-Value | 6.33 | |||||
Earnings Yield (Greenblatt) % | -29.6 | |||||
FCF Yield % | -27.84 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Creo Medical Group PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil £) | 30.3 | ||
EPS (TTM) (£) | -0.06 | ||
Beta | 1.06 | ||
Volatility % | 70.64 | ||
14-Day RSI | 65.14 | ||
14-Day ATR (£) | 0.013093 | ||
20-Day SMA (£) | 0.161488 | ||
12-1 Month Momentum % | -54.76 | ||
52-Week Range (£) | 0.12 - 0.5 | ||
Shares Outstanding (Mil) | 412.15 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Creo Medical Group PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Creo Medical Group PLC Stock Events
Event | Date | Price(£) | ||
---|---|---|---|---|
No Event Data |
Creo Medical Group PLC Frequently Asked Questions
What is Creo Medical Group PLC(LSE:CREO)'s stock price today?
When is next earnings date of Creo Medical Group PLC(LSE:CREO)?
Does Creo Medical Group PLC(LSE:CREO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |